Discover AtriCure's standout Q2 2025 performance with 17% revenue growth, boosted by product innovation and international expansion.

Johnson Controls International shares dropped after the company reported a lower profit in the third quarter. Shares fell 7.5% at $103.11 on Tuesday. The stock has been up 31% this year.

Company announcement No. 584, 2025 CHIEF EXECUTIVE OFFICER JÖRG BRINKMANN QUOTE "Despite significant improvement efforts over ...

Schneider adds that investors seem optimistic about American Tower due to stronger domestic organic growth heading into ...

He also noted raised outlooks in emerging markets, especially Africa, and described CoreSite as experiencing "exceptional performance" with increased 2025 expectations after the DE1 facility ...

The IMF revised its growth forecast for the South Asian country to 6.4% for both 2025 and 2026, up from the 6.2% it had projected in April. India's growth outlook reflects "a more benign external ...

Pharma giant Novo Nordisk A/S (NYSE:NVO) is plunging 21% to trade at a nearly three-year low of $54.27, after the company's ...

Novo Nordisk has named Maziar Mike Doustdar, currently the company’s EVP of international operations, as the new CEO.

The IMF on Tuesday raised its global growth forecasts for 2025 and 2026 slightly, citing stronger-than-expected purchases ...

The upgrade for emerging markets reflects a more optimistic outlook globally by the Fund, which nudged global GDP growth ...

In its world economic outlook, the IMF lifted its U.S. growth estimate for 2025 to 1.9% and the 2026 forecast to 2%. That's an increase of one-tenth of a percent this year and three-tenths of a ...

Novo Nordisk lowers 2025 guidance as Wegovy and Ozempic face slower U.S. uptake, competition, and continued compounded GLP-1 ...